๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
70.50
-0.30 (-0.42%)
Nov 20, 2026, 1:24 PM CST

WeLeader Biomedical Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,2661,109991.13940.71,036841.14
Revenue Growth
19.20%11.92%5.36%-9.17%23.13%-
Gross Profit
445.6370.97316.32298.08291.75218.92
Operating Income
323.87261.22214.14197.96194.64132.28
Net Income
263.85208.56170.21152.28153.8105.77
Earnings Per Share
5.194.524.083.715.053.76
EPS Growth
19.90%10.89%9.97%-26.53%34.31%-

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
The Company
921.45825.01786.04873.39742.56
Health Leader Biomedical Co., Ltd.
192.86166.38155.57165.55102.42
Adjustments and Write-Offs
-5.02-0.27-0.9-3.23-3.85
Total
1,109991.13940.71,036841.14

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
153.14334.71212.17104.95111.45118.71
Total Debt
1,030853.11796.77626701.25282.19
Net Cash (Debt)
-876.71-518.4-584.6-521.05-589.79-163.49
Net Cash Growth
------
Net Cash Per Share
-17.14-11.16-14.01-12.68-19.38-5.82

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
377.41313.3278.76231.86280.27238.03
Capital Expenditures
-77.6-212.74-170.71-114.73-659.36-21.6
Free Cash Flow
299.81100.56108.06117.13-379.09216.43
Free Cash Flow Growth
550.38%-6.94%-7.75%---

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
35.20%33.44%31.92%31.69%28.17%26.03%
Operating Margin
25.58%23.55%21.61%21.04%18.79%15.73%
Pretax Margin
25.73%23.53%21.71%20.57%18.59%15.63%
Profit Margin
20.84%18.80%17.17%16.19%14.85%12.57%
FCF Margin
23.68%9.06%10.90%12.45%-36.60%25.73%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
4.1004.1003.3702.3000.8600.450
Dividend Per Share Growth
21.73%21.66%46.52%167.44%91.11%-
Dividend Yield
5.82%5.59%4.32%---

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
13.5816.0119.05---
P/FCF Ratio
10.6933.2030.01---
PS Ratio
2.533.013.27---